SCHEMBL1664358

SCHEMBL1664358

O=C(Nc1ccc(C(=O)c2ccc(Nc3ccc(N4CCC(O)CC4)cc3)cc2)cc1)c1cc[nH]c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 10/20 0.46
RAB9A P51151 10/20 0.46
GFER P55789 1/20 0.45
SMN1; SMN2 Q16637 4/20 0.44
MAPT P10636 4/20 0.44
KMT2A Q03164 2/20 0.44
USP2 O75604 1/20 0.44
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44
LMNA P02545 1/20 0.44
MCL1 Q07820 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
KDM1A O60341 5/20 0.44
MAOA P21397 5/20 0.44
MAOB P27338 5/20 0.44
KDM1B Q8NB78 5/20 0.44
RCOR1 Q9UKL0 5/20 0.44
TP53 P04637 3/20 0.44
MAPK1 P28482 2/20 0.44
HDAC8 Q9BY41 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1666906 0.95 RAB9A (0.50) NPC1RAB9AGFERSMN1; SMN2MAPT
SCHEMBL1664360 0.95 RAB9A (0.50) NPC1RAB9AGFERSMN1; SMN2MAPT
SCHEMBL1666904 0.95 NPC1 (0.47) NPC1RAB9AGFERSMN1; SMN2MAPT
SCHEMBL1664469 0.86 RAB9A (0.58) NPC1RAB9ASMN1; SMN2MAPTKMT2A
SCHEMBL8769706 0.86 RAB9A (0.58) NPC1RAB9ASMN1; SMN2MAPTKMT2A
SCHEMBL1664758 0.85 MAPT (0.46) NPC1RAB9AGFERSMN1; SMN2MAPT
SCHEMBL1664879 0.85 NPC1 (0.41) NPC1RAB9ASMN1; SMN2MAPTKMT2A
SCHEMBL1665401 0.85 EGFR (0.44) NPC1RAB9ASMN1; SMN2MAPTKMT2A
SCHEMBL1664961 0.84 NPC1 (0.65) NPC1RAB9AGFERSMN1; SMN2MAPT
SCHEMBL1665398 0.84 EGFR (0.44) NPC1RAB9ASMN1; SMN2MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2642994-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS Ligand Pharmaceuticals Incorporated (US) 2013-10-02 EP disclosed
EP-2488486-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES Ligand Pharmaceuticals Inc. (US) 2012-08-22 EP disclosed
WO-2012068406-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS LIGAND PHARMACEUTICALS INCORPORATED (US) 2012-05-24 WO disclosed
WO-2011046954-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES LIGAND PHARMACEUTICALS INC. (US) 2011-04-21 WO disclosed